OPTIKINE
LIVE

Serial Number

50018552

Owner

InVitria, Inc.

Attorney

Dianne M. Smith-Misemer

Filing Date

Jul 28, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OPTIKINE Trademark

Serial Number: 50018552

OPTIKINE is a trademark filed by InVitria, Inc. on July 28, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

InVitria, Inc. (2 trademarks)

2718 Industrial Drive
Junction City, KS 66441

Entity Type: 03

Trademark Details

Filing Date

July 28, 2026

Registration Date

Not Registered

Goods & Services

Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for medical or veterinary purposes; Recombinant cytokine proteins for use as cell growth media for growing cells for clinical use; Recombinant cytokine proteins for use as reagents for clinical medical purposes; Recombinant cytokine protein arrays for clinical medical diagnosis purposes; Recombinant cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of immune system related diseases and disorders; Recombinant cytokine proteins for use as reagents for medical use, for the optimization of in vitro expansion of cells; Pharmaceutical preparations, namely, cytokine drugs for the optimization of in vitro expansion of cells

Recombinant cytokine proteins in raw material form for scientific and medical research use; Recombinant cytokine proteins for use in manufacture of pharmaceutical products, veterinary preparations, cellular therapies, gene therapies, regenerative medicines, and vaccines; Chemicals, namely, non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific and research use; Non-animal derived cell culture media for promoting cell growth, optimization, and productivity, for scientific, laboratory and medical research

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 28, 2026 MAFR
NEW APPLICATION ENTERED
Jul 28, 2026 NWAP